title: HBV in 2016: Global and immunotherapeutic insights into hepatitis B.
authors.affiliation: Division of Infection and Immunity, University College London, Rayne Institute, 5 University Street, London, WC1E 6JF, UK.
authors.forename: Mala K
authors.initials: MK
authors.lastname: Maini
authors.affiliation: Emerging Infectious Diseases Program, Duke-NUS Graduate Medical School, 8 College Road, 169857, Singapore; and at the Singapore Immunology Network (SigN) 8A Biomedical Grove, 138648, Singapore.
authors.forename: Antonio
authors.initials: A
authors.lastname: Bertoletti
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D006509:Hepatitis B / Q000517:prevention & control* / Q000635:transmission; D017325:Hepatitis B Vaccines; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007167:Immunotherapy
chemical_list: D000998:Antiviral Agents; D017325:Hepatitis B Vaccines; D007155:Immunologic Factors